


Healthcare News Roundup: Neuro
HSMN NewsFeed - 9 May 2022
BlueWind Medical Raises $64 Million to Fund Innovative Technology for Overactive Bladder (OAB) Treatment
BlueWind Medical Raises $64 Million to Fund Innovative Technology for Overactive Bladder (OAB) Treatment
HSMN NewsFeed - 2 May 2022
Supernus Announces FDA Approval of Qelbree(R) for the Treatment of ADHD in Adults
Supernus Announces FDA Approval of Qelbree(R) for the Treatment of ADHD in Adults
HSMN NewsFeed - 21 Apr 2022
NuVasive Simplify Cervical Disc Two-level Data Published in Journal of Neurosurgery: Spine
NuVasive Simplify Cervical Disc Two-level Data Published in Journal of Neurosurgery: Spine
HSMN NewsFeed - 21 Apr 2022
Wallaby Acquires German Neurovascular Leader Phenox to Accelerate Global Expansion
Wallaby Acquires German Neurovascular Leader Phenox to Accelerate Global Expansion
HSMN NewsFeed - 4 Apr 2022
Invitae Introduces First Comprehensive Genetic Test Suite for Neurodevelopmental Disorders
Invitae Introduces First Comprehensive Genetic Test Suite for Neurodevelopmental Disorders
HSMN NewsFeed - 30 Mar 2022
Neuron23 Closes $100 Million Series C Financing Round, Nominates Clinical Candidate for Parkinson's Disease
Neuron23 Closes $100 Million Series C Financing Round, Nominates Clinical Candidate for Parkinson's Disease
HSMN NewsFeed - 28 Mar 2022
Jazz Pharmaceuticals Announces Agreement to Divest Sunosi(R) (solriamfetol) to Axsome Therapeutics
Jazz Pharmaceuticals Announces Agreement to Divest Sunosi(R) (solriamfetol) to Axsome Therapeutics
